C

CorMedix
D

CRMD

10.865
USD
-0.21
(-1.85%)
مغلق
حجم التداول
34,019
الربح لكل سهم
1
العائد الربحي
-
P/E
43
حجم السوق
808,672,889
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ 9 أشهر
buy
2024-10-03 07:52
CRMD Chart
المزيد
أصول ذات صلة
A
AGEN
-0.58000
(-8.62%)
6.14500 USD
A
AKBA
-0.03000
(-0.77%)
3.85000 USD
C
CLRB
-0.11000
(-2.18%)
4.93000 USD
D
DVAX
0.040
(0.37%)
10.720 USD
M
MDGL
-14.23
(-4.08%)
334.13 USD
R
RDHL
-0.59000
(-24.08%)
1.86000 USD
R
RMTI
0.00500
(0.46%)
1.09500 USD
S
SNDX
-0.20000
(-2.07%)
9.47000 USD
المزيد
الأخبار المقالات

العنوان: CorMedix

القطاع: Healthcare
الصناعة: Biotechnology
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.